Equities research analysts expect athenahealth, Inc (NASDAQ:ATHN) to post $0.74 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Twenty Two analysts have made estimates for athenahealth’s earnings, with estimates ranging from $0.38 to $0.90. athenahealth reported earnings per share of $0.32 in the same quarter last year, which would indicate a positive year-over-year growth rate of 131.3%. The firm is expected to report its next quarterly earnings results after the market closes on Thursday, April 26th.
On average, analysts expect that athenahealth will report full year earnings of $3.79 per share for the current year, with EPS estimates ranging from $3.10 to $4.15. For the next financial year, analysts anticipate that the company will post earnings of $4.49 per share, with EPS estimates ranging from $3.72 to $5.42. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research analysts that follow athenahealth.
athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, February 1st. The health services provider reported $1.11 EPS for the quarter, topping the consensus estimate of $0.63 by $0.48. The company had revenue of $329.20 million for the quarter, compared to analysts’ expectations of $319.64 million. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The business’s revenue for the quarter was up 14.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.62 earnings per share.
Shares of ATHN stock traded up $1.78 during trading hours on Wednesday, hitting $143.98. 63,077 shares of the company’s stock were exchanged, compared to its average volume of 484,189. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.84 and a current ratio of 1.84. The stock has a market capitalization of $5,701.91, a PE ratio of 91.93, a PEG ratio of 2.97 and a beta of 1.13. athenahealth has a 52 week low of $95.01 and a 52 week high of $158.66.
In other athenahealth news, SVP Bradford Kyle Armbrester sold 2,235 shares of the stock in a transaction dated Friday, March 2nd. The stock was sold at an average price of $138.70, for a total value of $309,994.50. Following the transaction, the senior vice president now owns 10,146 shares of the company’s stock, valued at $1,407,250.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Jonathan Bush sold 5,000 shares of the stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $122.69, for a total value of $613,450.00. Following the completion of the transaction, the chief executive officer now directly owns 320,807 shares in the company, valued at approximately $39,359,810.83. The disclosure for this sale can be found here. Insiders have sold 47,555 shares of company stock worth $6,682,463 in the last ninety days. 3.20% of the stock is currently owned by insiders.
A number of large investors have recently added to or reduced their stakes in the business. The Manufacturers Life Insurance Company lifted its stake in athenahealth by 7.7% in the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after buying an additional 84 shares during the period. Alliancebernstein L.P. lifted its stake in athenahealth by 1.8% in the fourth quarter. Alliancebernstein L.P. now owns 22,790 shares of the health services provider’s stock valued at $3,032,000 after buying an additional 400 shares during the period. Amalgamated Bank lifted its stake in athenahealth by 5.7% in the fourth quarter. Amalgamated Bank now owns 7,892 shares of the health services provider’s stock valued at $1,050,000 after buying an additional 427 shares during the period. Stifel Financial Corp lifted its stake in athenahealth by 7.1% in the third quarter. Stifel Financial Corp now owns 8,828 shares of the health services provider’s stock valued at $1,094,000 after buying an additional 582 shares during the period. Finally, Fox Run Management L.L.C. lifted its stake in athenahealth by 19.2% in the fourth quarter. Fox Run Management L.L.C. now owns 4,412 shares of the health services provider’s stock valued at $587,000 after buying an additional 712 shares during the period.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.